Immunotherapy treatment option for some adults with leukemia
Patients living with a specific type of leukemia will have access to a new immunotherapy treatment on the NHS in England.
Jun 20, 2019
0
1
Patients living with a specific type of leukemia will have access to a new immunotherapy treatment on the NHS in England.
Jun 20, 2019
0
1
Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer. The altered cells remain active for years after the ...
Jun 18, 2019
0
3
An international team of researchers at VIB-KU Leuven, Belgium, the U.K. Dementia Institute and the Children's Cancer Institute, Australia, have found a safer treatment for a specific type of leukemia. By refining a therapeutic ...
May 29, 2019
0
31
Nearly 90 percent of children with acute lymphoblastic leukemia (ALL) survive, yet the same treatments that save their life can adversely affect their quality of life and cardiorespiratory fitness health. In fact, the cardiorespiratory ...
May 29, 2019
0
0
A study led by St. Jude Children's Research Hospital has identified a novel risk variant associated with T cell acute lymphoblastic leukemia (T-ALL). The findings appear as an advance online publication in the Journal of ...
Apr 2, 2019
0
5
(HealthDay)—For children with B-cell precursor acute lymphoblastic leukemia with late bone marrow relapse, risk stratification by minimal residual disease seems to be an effective strategy for treatment, according to a ...
Mar 19, 2019
0
2
(HealthDay)—Almost half of elderly patients newly diagnosed with acute lymphoblastic leukemia (ALL) do not receive treatment, according to a study recently published in Leukemia & Lymphoma.
Mar 8, 2019
0
5
(HealthDay)—For children with acute lymphoblastic leukemia (ALL), obesity is associated with an increased risk for adverse events during premaintenance chemotherapy, according to a study published in the February issue ...
Feb 13, 2019
0
2
AICAr (5-amino-4-imidazolecarboxamide riboside, also called Acadesine) has been found to inhibit cell proliferation and has cytotoxic potential for childhood acute lymphoblastic leukemia (ALL) cells. Much of the drug's cytotoxic ...
Jan 31, 2019
0
1
Acute T-cell lymphoblastic leukemia is a rare type of blood cancer that affects mostly children. This blood cancer appears from the precursor cells that produce T lymphocytes (a type of white blood cells). A new study from ...
Jan 25, 2019
0
0